Target intelligence / Profile preview

RNA, U6 small nuclear 220, pseudogene (RNU6-220P)

Target: RNU6-220P
Molecular classification: Other (non-coding RNA pseudogene)

Overview

RNU6-220P is a human pseudogene related to the U6 small nuclear RNA (snRNA) gene family. U6 snRNA is an essential component of the spliceosome, responsible for catalyzing pre-mRNA splicing in eukaryotic cells. However, RNU6-220P itself is classified as a pseudogene, meaning it is thought to be non-functional and generally does not encode a functional RNA or protein product. There is no evidence in the current literature that RNU6-220P has a biological role, is involved in disease, or serves as a therapeutic target.

Other names: RNU6-220PU6-220P

Mechanism of action

None

Biological functions

None established for the pseudogene itself

Disease associations

None reported for RNU6-220P

Beyond the preview

Go deeper on RNA, U6 small nuclear 220, pseudogene (RNU6-220P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 220, pseudogene (RNU6-220P).

Explore the full profile